Press releaseGlobe Newswire
SeaStar Medical Holding
ICU · NASDAQ
$3.05−$0.06 (−1.93%)TodayMarket closed ·
Prev close $3.11
Latest news
- News
SeaStar Medical Receives FDA's Medical Breakthrough Device Designation For Its Selective Cytopheretic Device Therapy To Treat Hyperinflammation
- Press releaseGlobe Newswire
FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition
- Press releaseGlobe Newswire
SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds
- Press releaseGlobe Newswire
New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)
- Press releaseGlobe Newswire
SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026
- Press releaseGlobe Newswire
SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy
- Press releaseGlobe Newswire
SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates
- Press releaseGlobe Newswire
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
- Press releaseGlobe Newswire
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
- News
Full Transcript: SeaStar Medical Holding Q1 2026 Earnings Call
- News
Earnings Scheduled For May 13, 2026
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
Earnings Scheduled For March 25, 2026
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Why Oracle Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
Earnings Scheduled For November 13, 2025
- News
A Glimpse of SeaStar Medical Holding's Earnings Potential
- Press releaseGlobe Newswire
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025
- NewsAvi Kapoor
Nasdaq Down Over 1%; US Initial Jobless Claims Fall
- News
SeaStar Medical Announces That Independent DSMB Recommends Continuing NEUTRALIZE-AKI Pivotal Trial Of Its Selective Cytopheretic Device Therapy For Adult Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy
- Press releaseGlobe Newswire
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
- NewsAvi Kapoor
Crude Oil Rises Sharply; Torrid Holdings Shares Plunge
- NewsAvi Kapoor
US Stocks Mixed; General Mills Shares Fall After Q4 Results
- Press releasePRNewswire
NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award
- Press releaseGlobe Newswire
SEASTAR ALERT: Bragar Eagel & Squire, P.C. is Investigating SeaStar Medical Holding Corp on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
- Press releasePRNewswire
Shareholders that lost money on SeaStar Medical Holding Corporation(ICU) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- Press releaseBusiness Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SeaStar Medical Holding Corporation (ICU)
- Press releaseBusiness Wire
ICU Deadline: Rosen Law Firm Urges SeaStar Medical Holding Corporation (ICU, ICUCW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
- Press releasePRNewswire
September 6, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against ICU
- Press releasePRNewswire
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit
- Press releasePRNewswire
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in SeaStar Medical Holding Corporation of Class Action Lawsuit and Upcoming Deadlines - ICU
- Press releasePRNewswire
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit
- Press releasePRNewswire
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit with the Schall Law Firm
- Press releasePRNewswire
ICU LAWSUIT ALERT: Levi & Korsinsky Notifies SeaStar Medical Holding Corporation Investors of a Class Action Lawsuit and Upcoming Deadline
- Press releasePRNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
- Press releaseGlobe Newswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SeaStar
- Press releasePRNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of SeaStar Medical Holding Corporation(ICU) Shareholders
- Press releaseGlobe Newswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SeaStar Medical Holding Corporation (ICU)
- Press releasePRNewswire
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit
- Press releasePRNewswire
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation Securities Fraud Lawsuit with the Schall Law Firm
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.